 | • レポートコード：GIR-2104Z02221 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、バイオマーカー検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。バイオマーカー検査の種類別市場規模（がん、心血管、感染症、中枢神経系）、用途別市場規模（製薬・バイオテクノロジー産業、診断ツール産業、医療IT /ビッグデータ産業、臨床検査室）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・バイオマーカー検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：F. Hoffmann-La Roche、Novartis、PFIZER、GlaxoSmithKline、GE Healthcare、Medtronics、Quest Diagnostics ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：がん、心血管、感染症、中枢神経系 ・用途別分析2016年-2026年：製薬・バイオテクノロジー産業、診断ツール産業、医療IT /ビッグデータ産業、臨床検査室 ・バイオマーカー検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・バイオマーカー検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・バイオマーカー検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・バイオマーカー検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・バイオマーカー検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Biomarker Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Biomarker Test size is estimated to be USD xx million in 2025 from USD xx million in 2019, with a change XX% between 2019 and 2020. The global Biomarker Test market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Biomarker Test market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cancer
Cardiovascular
Infectious Diseases
Central Nervous System
Market segment by Application, can be divided into
Pharma & Biotech Companies
Diagnostic tool companies
Healthcare IT/Big data companies
Clinical laboratories
Market segment by players, this report covers
F. Hoffmann-La Roche
Novartis
PFIZER
GlaxoSmithKline
GE Healthcare
Medtronics
Quest Diagnostics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Biomarker Test
1.2 Classification of Biomarker Test by Type
1.2.1 Overview: Global Biomarker Test Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Biomarker Test Revenue Market Share by Type in 2020
1.2.3 Cancer
1.2.4 Cardiovascular
1.2.5 Infectious Diseases
1.2.6 Central Nervous System
1.3 Global Biomarker Test Market by Application
1.3.1 Overview: Global Biomarker Test Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Pharma & Biotech Companies
1.3.3 Diagnostic tool companies
1.3.4 Healthcare IT/Big data companies
1.3.5 Clinical laboratories
1.4 Global Biomarker Test Market Size & Forecast
1.5 Global Biomarker Test Market Size and Forecast by Region
1.5.1 Global Biomarker Test Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Biomarker Test Market Size by Region, (2016-2021)
1.5.3 North America Biomarker Test Market Size and Prospect (2016-2026)
1.5.4 Europe Biomarker Test Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Biomarker Test Market Size and Prospect (2016-2026)
1.5.6 South America Biomarker Test Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Biomarker Test Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biomarker Test Market Drivers
1.6.2 Biomarker Test Market Restraints
1.6.3 Biomarker Test Trends Analysis
2 Company Profiles
2.1 F. Hoffmann-La Roche
2.1.1 F. Hoffmann-La Roche Details
2.1.2 F. Hoffmann-La Roche Major Business
2.1.3 F. Hoffmann-La Roche Biomarker Test Product and Solutions
2.1.4 F. Hoffmann-La Roche Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 F. Hoffmann-La Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Biomarker Test Product and Solutions
2.2.4 Novartis Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Novartis Recent Developments and Future Plans
2.3 PFIZER
2.3.1 PFIZER Details
2.3.2 PFIZER Major Business
2.3.3 PFIZER Biomarker Test Product and Solutions
2.3.4 PFIZER Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 PFIZER Recent Developments and Future Plans
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Biomarker Test Product and Solutions
2.4.4 GlaxoSmithKline Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 GlaxoSmithKline Recent Developments and Future Plans
2.5 GE Healthcare
2.5.1 GE Healthcare Details
2.5.2 GE Healthcare Major Business
2.5.3 GE Healthcare Biomarker Test Product and Solutions
2.5.4 GE Healthcare Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 GE Healthcare Recent Developments and Future Plans
2.6 Medtronics
2.6.1 Medtronics Details
2.6.2 Medtronics Major Business
2.6.3 Medtronics Biomarker Test Product and Solutions
2.6.4 Medtronics Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Medtronics Recent Developments and Future Plans
2.7 Quest Diagnostics
2.7.1 Quest Diagnostics Details
2.7.2 Quest Diagnostics Major Business
2.7.3 Quest Diagnostics Biomarker Test Product and Solutions
2.7.4 Quest Diagnostics Biomarker Test Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Quest Diagnostics Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biomarker Test Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 5 Biomarker Test Players Market Share
3.2.2 Top 10 Biomarker Test Players Market Share
3.2.3 Market Competition Trend
3.3 Biomarker Test Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biomarker Test Revenue and Market Share by Type (2016-2021)
4.2 Global Biomarker Test Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biomarker Test Revenue Market Share by Application (2016-2021)
5.2 Biomarker Test Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biomarker Test Revenue by Type (2016-2026)
6.2 North America Biomarker Test Revenue by Application (2016-2026)
6.3 North America Biomarker Test Market Size by Country
6.3.1 North America Biomarker Test Revenue by Country (2016-2026)
6.3.2 United States Biomarker Test Market Size and Forecast (2016-2026)
6.3.3 Canada Biomarker Test Market Size and Forecast (2016-2026)
6.3.4 Mexico Biomarker Test Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Biomarker Test Revenue by Type (2016-2026)
7.2 Europe Biomarker Test Revenue by Application (2016-2026)
7.3 Europe Biomarker Test Market Size by Country
7.3.1 Europe Biomarker Test Revenue by Country (2016-2026)
7.3.2 Germany Biomarker Test Market Size and Forecast (2016-2026)
7.3.3 France Biomarker Test Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Biomarker Test Market Size and Forecast (2016-2026)
7.3.5 Russia Biomarker Test Market Size and Forecast (2016-2026)
7.3.6 Italy Biomarker Test Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biomarker Test Revenue by Type (2016-2026)
8.2 Asia-Pacific Biomarker Test Revenue by Application (2016-2026)
8.3 Asia-Pacific Biomarker Test Market Size by Region
8.3.1 Asia-Pacific Biomarker Test Revenue by Region (2016-2026)
8.3.2 China Biomarker Test Market Size and Forecast (2016-2026)
8.3.3 Japan Biomarker Test Market Size and Forecast (2016-2026)
8.3.4 South Korea Biomarker Test Market Size and Forecast (2016-2026)
8.3.5 India Biomarker Test Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Biomarker Test Market Size and Forecast (2016-2026)
8.3.7 Australia Biomarker Test Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Biomarker Test Revenue by Type (2016-2026)
9.2 South America Biomarker Test Revenue by Application (2016-2026)
9.3 South America Biomarker Test Market Size by Country
9.3.1 South America Biomarker Test Revenue by Country (2016-2026)
9.3.2 Brazil Biomarker Test Market Size and Forecast (2016-2026)
9.3.3 Argentina Biomarker Test Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biomarker Test Revenue by Type (2016-2026)
10.2 Middle East & Africa Biomarker Test Revenue by Application (2016-2026)
10.3 Middle East & Africa Biomarker Test Market Size by Country
10.3.1 Middle East & Africa Biomarker Test Revenue by Country (2016-2026)
10.3.2 Turkey Biomarker Test Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Biomarker Test Market Size and Forecast (2016-2026)
10.3.4 UAE Biomarker Test Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Biomarker Test Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Biomarker Test Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Biomarker Test Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Biomarker Test Revenue (USD Million) by Region (2016-2021)
Table 5. Global Biomarker Test Revenue Market Share by Region (2021-2026)
Table 6. F. Hoffmann-La Roche Corporate Information, Head Office, and Major Competitors
Table 7. F. Hoffmann-La Roche Major Business
Table 8. F. Hoffmann-La Roche Biomarker Test Product and Solutions
Table 9. F. Hoffmann-La Roche Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Novartis Corporate Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Biomarker Test Product and Solutions
Table 13. Novartis Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. PFIZER Corporate Information, Head Office, and Major Competitors
Table 15. PFIZER Major Business
Table 16. PFIZER Biomarker Test Product and Solutions
Table 17. PFIZER Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. GlaxoSmithKline Corporate Information, Head Office, and Major Competitors
Table 19. GlaxoSmithKline Major Business
Table 20. GlaxoSmithKline Biomarker Test Product and Solutions
Table 21. GlaxoSmithKline Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. GE Healthcare Corporate Information, Head Office, and Major Competitors
Table 23. GE Healthcare Major Business
Table 24. GE Healthcare Biomarker Test Product and Solutions
Table 25. GE Healthcare Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Medtronics Corporate Information, Head Office, and Major Competitors
Table 27. Medtronics Major Business
Table 28. Medtronics Biomarker Test Product and Solutions
Table 29. Medtronics Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Quest Diagnostics Corporate Information, Head Office, and Major Competitors
Table 31. Quest Diagnostics Major Business
Table 32. Quest Diagnostics Biomarker Test Product and Solutions
Table 33. Quest Diagnostics Biomarker Test Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Global Biomarker Test Revenue (USD Million) by Players (2019-2021)
Table 35. Global Biomarker Test Revenue Share by Players (2019-2021)
Table 36. Breakdown of Biomarker Test by Company Type (Tier 1, Tier 2 and Tier 3)
Table 37. Biomarker Test Players Head Office, Products and Services Provided
Table 38. Biomarker Test Mergers & Acquisitions in the Past Five Years
Table 39. Biomarker Test New Entrants and Expansion Plans
Table 40. Global Biomarker Test Revenue (USD Million) by Type (2016-2021)
Table 41. Global Biomarker Test Revenue Share by Type (2016-2021)
Table 42. Global Biomarker Test Revenue Forecast by Type (2021-2026)
Table 43. Global Biomarker Test Revenue by Application (2016-2021)
Table 44. Global Biomarker Test Revenue Forecast by Application (2021-2026)
Table 45. North America Biomarker Test Revenue by Type (2016-2021) & (USD Million)
Table 46. North America Biomarker Test Revenue by Type (2021-2026) & (USD Million)
Table 47. North America Biomarker Test Revenue by Application (2016-2021) & (USD Million)
Table 48. North America Biomarker Test Revenue by Application (2021-2026) & (USD Million)
Table 49. North America Biomarker Test Revenue by Country (2016-2021) & (USD Million)
Table 50. North America Biomarker Test Revenue by Country (2021-2026) & (USD Million)
Table 51. Europe Biomarker Test Revenue by Type (2016-2021) & (USD Million)
Table 52. Europe Biomarker Test Revenue by Type (2021-2026) & (USD Million)
Table 53. Europe Biomarker Test Revenue by Application (2016-2021) & (USD Million)
Table 54. Europe Biomarker Test Revenue by Application (2021-2026) & (USD Million)
Table 55. Europe Biomarker Test Revenue by Country (2016-2021) & (USD Million)
Table 56. Europe Biomarker Test Revenue by Country (2021-2026) & (USD Million)
Table 57. Asia-Pacific Biomarker Test Revenue by Type (2016-2021) & (USD Million)
Table 58. Asia-Pacific Biomarker Test Revenue by Type (2021-2026) & (USD Million)
Table 59. Asia-Pacific Biomarker Test Revenue by Application (2016-2021) & (USD Million)
Table 60. Asia-Pacific Biomarker Test Revenue by Application (2021-2026) & (USD Million)
Table 61. Asia-Pacific Biomarker Test Revenue by Region (2016-2021) & (USD Million)
Table 62. Asia-Pacific Biomarker Test Revenue by Region (2021-2026) & (USD Million)
Table 63. South America Biomarker Test Revenue by Type (2016-2021) & (USD Million)
Table 64. South America Biomarker Test Revenue by Type (2021-2026) & (USD Million)
Table 65. South America Biomarker Test Revenue by Application (2016-2021) & (USD Million)
Table 66. South America Biomarker Test Revenue by Application (2021-2026) & (USD Million)
Table 67. South America Biomarker Test Revenue by Country (2016-2021) & (USD Million)
Table 68. South America Biomarker Test Revenue by Country (2021-2026) & (USD Million)
Table 69. Middle East & Africa Biomarker Test Revenue by Type (2016-2021) & (USD Million)
Table 70. Middle East & Africa Biomarker Test Revenue by Type (2021-2026) & (USD Million)
Table 71. Middle East & Africa Biomarker Test Revenue by Application (2016-2021) & (USD Million)
Table 72. Middle East & Africa Biomarker Test Revenue by Application (2021-2026) & (USD Million)
Table 73. Middle East & Africa Biomarker Test Revenue by Country (2016-2021) & (USD Million)
Table 74. Middle East & Africa Biomarker Test Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Biomarker Test Picture
Figure 2. Global Biomarker Test Revenue Market Share by Type in 2020
Figure 3. Cancer
Figure 4. Cardiovascular
Figure 5. Infectious Diseases
Figure 6. Central Nervous System
Figure 7. Biomarker Test Revenue Market Share by Application in 2020
Figure 8. Pharma & Biotech Companies Picture
Figure 9. Diagnostic tool companies Picture
Figure 10. Healthcare IT/Big data companies Picture
Figure 11. Clinical laboratories Picture
Figure 12. Global Biomarker Test Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Biomarker Test Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Biomarker Test Revenue Market Share by Region (2016-2026)
Figure 15. Global Biomarker Test Revenue Market Share by Region in 2020
Figure 16. North America Biomarker Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Biomarker Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Biomarker Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Biomarker Test Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Biomarker Test Market Drivers
Figure 21. Biomarker Test Market Restraints
Figure 22. Biomarker Test Market Trends
Figure 23. F. Hoffmann-La Roche Recent Developments and Future Plans
Figure 24. Novartis Recent Developments and Future Plans
Figure 25. PFIZER Recent Developments and Future Plans
Figure 26. GlaxoSmithKline Recent Developments and Future Plans
Figure 27. GE Healthcare Recent Developments and Future Plans
Figure 28. Medtronics Recent Developments and Future Plans
Figure 29. Quest Diagnostics Recent Developments and Future Plans
Figure 31. Global Biomarker Test Revenue Share by Players in 2020
Figure 32. Biomarker Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 33. Global Top 3 Players Biomarker Test Revenue Market Share in 2020
Figure 34. Global Top 10 Players Biomarker Test Revenue Market Share in 2020
Figure 35. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 36. Global Biomarker Test Revenue Share by Type in 2020
Figure 37. Global Biomarker Test Market Share Forecast by Type (2021-2026)
Figure 38. Global Biomarker Test Revenue Share by Application in 2020
Figure 39. Global Biomarker Test Market Share Forecast by Application (2021-2026)
Figure 40. North America Biomarker Test Sales Market Share by Type (2016-2026)
Figure 41. North America Biomarker Test Sales Market Share by Application (2016-2026)
Figure 42. North America Biomarker Test Revenue Market Share by Country (2016-2026)
Figure 43. United States Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Biomarker Test Sales Market Share by Type (2016-2026)
Figure 47. Europe Biomarker Test Sales Market Share by Application (2016-2026)
Figure 48. Europe Biomarker Test Revenue Market Share by Country (2016-2026)
Figure 49. Germany Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. France Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. United Kingdom Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Russia Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Italy Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Asia-Pacific Biomarker Test Sales Market Share by Type (2016-2026)
Figure 55. Asia-Pacific Biomarker Test Sales Market Share by Application (2016-2026)
Figure 56. Asia-Pacific Biomarker Test Revenue Market Share by Region (2016-2026)
Figure 57. China Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South Korea Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America Biomarker Test Sales Market Share by Type (2016-2026)
Figure 64. South America Biomarker Test Sales Market Share by Application (2016-2026)
Figure 65. South America Biomarker Test Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East and Africa Biomarker Test Sales Market Share by Type (2016-2026)
Figure 69. Middle East and Africa Biomarker Test Sales Market Share by Application (2016-2026)
Figure 70. Middle East and Africa Biomarker Test Revenue Market Share by Country (2016-2026)
Figure 71. Turkey Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 72. Saudi Arabia Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. UAE Biomarker Test Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Methodology
Figure 75. Research Process and Data Source
世界のバイオマーカー検査市場規模・現状・予測（2021年-2027年） Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. Steadily over latest years, the analytic manner has turned out to be more potent by means of the need to preselect sufferers in mild of medicines and licenses. This flow has come to through various…- 世界の腫瘍バイオマーカー検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界のボーカルバイオマーカー市場規模・現状・予測（2021年-2027年） Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs in the healthcare sector have led to the development of a unique diagnostic tool known…
- 世界の前立腺がんバイオマーカー市場規模・現状・予測（2021年-2027年） Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system. The prostate cancer biomarker market is expected to witness a fast growth owing to rising prevalence of prostate cancer. Market Analysis and Insights: Global Prostate Cancer Biomarker Market The gl…
- 世界のバイオマーカー市場規模・現状・予測（2021年-2027年） Biomarkers (short for biological markers) are biological measures of a biological state. By definition, a biomarker is "a characteristic that is objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes or pharmacological responses to a therapeutic inter…